Solanki Nilay, Bhavsar Shailesh
Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus Changa 388421, Gujarat, India.
Department of Veterinary Pharmacology and Toxicology, Kamdhenu University Anand, Gujarat, India.
Am J Transl Res. 2023 Oct 15;15(10):6148-6158. eCollection 2023.
In diabetic neuropathy with neurodegeneration (DNN), a serious diabetes consequence, extreme hyperglycemia destroys neurons in the brain and limbs. The main therapies for this condition are glucose control and pain management. Phytopharmacology is thought to be more successful in addressing the pain and blood sugar management issues associated with DNN. The objective of this study was to investigate how Bauhinia variegata (BV) could offer protection against streptozotocin (STZ)-induced diabetic neuropathy.
STZ-associated DNN was induced in rats, and these diabetic rats were treated with BV at 200 mg/kg and 400 mg/kg doses for 28 days. Blood glucose (BG), serum nitrite, lipid peroxidation, antioxidants, C-reactive protein, behavioral, and histopathological parameters were assessed.
BV dramatically reduced BG and HbA1c levels in diabetic rats, according to the findings. The levels of superoxide dismutase and catalase both rose significantly. Both lipid peroxidation and serum nitrite levels were drastically decreased with BV treatment. In this study, it was found that BV has anti-hyperglycemic and anti-inflammatory effects on DNN. This was shown by a significant drop in C-reactive protein in diabetic rats, which was a key factor in diabetic neuropathy. Thermal hyperalgesia was significantly alleviated after BV therapy, and diabetic rats' pain thresholds improved.
Present study concluded that BV treatment has excellent glycemic control, a high antioxidant status, and relevant pain-relieving potential in diabetic neuropathy with neurodegeneration by reversing thermal hyperalgesia and decreasing hypeglycemia in diabetic rats.
在伴有神经退行性变的糖尿病神经病变(DNN)中,这一严重的糖尿病并发症,极度高血糖会破坏大脑和四肢的神经元。该病症的主要治疗方法是控制血糖和疼痛管理。植物药理学在解决与DNN相关的疼痛和血糖管理问题方面被认为更有成效。本研究的目的是调查羊蹄甲(BV)如何对链脲佐菌素(STZ)诱导的糖尿病神经病变提供保护作用。
在大鼠中诱导出与STZ相关的DNN,这些糖尿病大鼠分别以200毫克/千克和400毫克/千克的剂量用BV治疗28天。评估血糖(BG)、血清亚硝酸盐、脂质过氧化、抗氧化剂、C反应蛋白、行为和组织病理学参数。
根据研究结果,BV显著降低了糖尿病大鼠的BG和糖化血红蛋白(HbA1c)水平。超氧化物歧化酶和过氧化氢酶水平均显著升高。BV治疗后脂质过氧化和血清亚硝酸盐水平均大幅下降。在本研究中,发现BV对DNN具有抗高血糖和抗炎作用。糖尿病大鼠中C反应蛋白显著下降表明了这一点,C反应蛋白是糖尿病神经病变的关键因素。BV治疗后热痛觉过敏明显减轻,糖尿病大鼠的疼痛阈值有所改善。
本研究得出结论,BV治疗在伴有神经退行性变的糖尿病神经病变中具有出色的血糖控制、高抗氧化状态和相关的止痛潜力,通过逆转热痛觉过敏和降低糖尿病大鼠的高血糖水平来实现。